Sage Journals: Discover world-class research

Abstract

Aim

We examined the advantages of thoracoscopy over thoracotomy in terms of perioperative outcomes and toleration of adjuvant chemotherapy.

Methods

Between April 2010 and March 2013, 657 patients with non-small-cell lung cancer who underwent lobectomy were classified into thoracoscopy (308 patients) and thoracotomy (349 patients) groups and compared.

Results

The thoracoscopy group had less blood loss compared to the thoracotomy group (p < 0.001). When limiting the analysis to pathological stage I patients, the results were similar (p < 0.001). In addition, the difference in blood loss between the 2 groups was greater in patients with severe pleural adhesions. The postoperative morbidity of the thoracoscopy group was significantly less than that of the thoracotomy group (13.3% vs. 21.2%, p < 0.001), and this result was similar when analyzing the pathological stage I patients (12.6% vs. 20.6%, p = 0.001). A higher percentage of the thoracoscopy group received both the full planned course and dose of adjuvant chemotherapy compared to the thoracotomy group (84.2% vs. 65.8%, p = 0.032).

Conclusions

These results indicate that totally thoracoscopic lobectomy is the more beneficial surgical approach with regard to the incidence of postoperative complications and toleration of adjuvant chemotherapy.

Keywords

Carcinoma non-small-cell lung Chemotherapy adjuvant Lobectomy Postoperative complications Thoracic surgery video-assisted Thoracotomy

Get full access to this article

View all access options for this article.

References

Villamizar

Darrabie

Burfeind

. Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. J Thorac Cardiovasc Surg 2009; 138: 419–425.

Paul

Altorki

Sheng

. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010; 139: 366–378.

Scott

Allen

Darling

. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg 2010; 139: 976–981.

Swanson

Meyers

Gunnarsson

. Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy: a retrospective multiinstitutional database analysis. Ann Thorac Surg 2012; 93: 1027–1032.

Cao

Manganas

Ang

Peeceeyen

Yan

. Video-assisted thoracic surgery versus open thoracotomy for non-small cell lung cancer: a meta-analysis of propensity score-matched patients. Interact Cardiovasc Thorac Surg 2013; 16: 244–249.

Iwata

. Minimally invasive pulmonary surgery for lung cancer, up to date. Gen Thorac Cardiovasc Surg 2013; 61: 449–454.

Winton

Livingston

Johnson

. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352: 2589–2597.

Douillard

Rosell

De Lena

. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006; 7: 719–727.

Strauss

Herndon

Maddaus

. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008; 26: 5043–5051.

10.

Arriagada

Dunant

Pignon

. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol 2010; 28: 35–42.

11.

Petersen

Pham

Burfeind

. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 2007; 83: 1245–1249.

12.

Nicastri

Wisnivesky

Litle

. Thoracoscopic lobectomy: report on safety, discharge, independence, pain, and chemotherapy tolerance. J Thorac Cardiovasc Surg 2008; 135: 642–647.

13.

Lee

Cho

Bae

. Thoracoscopic lobectomy is associated with superior compliance with adjuvant chemotherapy in lung cancer. Ann Thorac Surg 2011; 91: 344–348.

14.

Charlson

Pompei

Ales

MacKenzie

. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.

15.

Alam

Shepherd

Winton

. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer 2005; 47: 385–394.

16.

Yim

Wan

Lee

Arifi

. VATS lobectomy reduces cytokine responses compared with conventional surgery. Ann Thorac Surg 2000; 70: 243–247.

17.

Lee

Wan

. Thoracotomy is associated with significantly more profound suppression in lymphocytes and natural killer cells than video-assisted thoracic surgery following major lung resections for cancer. J Invest Surg 2005; 18: 81–88.

18.

Whelan

Lacy

Yim

. Is minimal access surgery for cancer associated with immunologic benefits? World J Surg 2005; 29: 975–981.

19.

Pepys

Hirschfield

. C-reactive protein: a critical update [Review]. J Clin Invest 2003; 111: 1805–1812.

20.

Zhong

Yao

Zhao

. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer. Ann Thorac Surg 2013; 95: 987–992.